Cargando…
AM281, Cannabinoid Antagonist/Inverse agonist, Ameliorates Scopolamine-Induced Cognitive Deficit
OBJECTIVE(S): Cannabinoids have been implicated in memory deficit. We examined the effect of AM281, cannabinoid antagonist/inverse agonist in prevention of scopolamine-induced cognitive deficit. MATERIALS AND METHODS: Object recognition task was used to evaluate memory in mice. Exploration time in t...
Autores principales: | Rabbani, Mohammed, Vaseghi, Golnaz, Hajhashemi, Valiollah |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Mashhad University of Medical Sciences
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3586915/ https://www.ncbi.nlm.nih.gov/pubmed/23493185 |
Ejemplares similares
-
The effect of AM281, a cannabinoid antagonist, on memory performance during spontaneous morphine withdrawal in mice
por: Vaseghi, G., et al.
Publicado: (2013) -
A Pilot Study into the Effects of the CB1 Cannabinoid Receptor Agonist WIN55,212-2 or the Antagonist/Inverse Agonist AM251 on Sleep in Rats
por: Goonawardena, Anushka V., et al.
Publicado: (2011) -
The Cannabinoid Receptor 1 Reverse Agonist AM251 Ameliorates Radiation-Induced Cognitive Decrements
por: Parihar, Vipan K., et al.
Publicado: (2021) -
Evaluation of the effect of Cyperus rotundus L. in scopolamine-induced learning deficit in mice
por: Rabbani, Mohammed, et al.
Publicado: (2014) -
Beneficial effects of pumpkin seed oil as a topical hair growth promoting agent in a mice model
por: Hajhashemi, Valiollah, et al.
Publicado: (2019)